US approves first vaccine against chikungunya virus
The vaccine, which will be marketed under the name Ixchiq, was approved for people 18 and over who are at increased risk of exposure, the Food and Drug Administration said Thursday. The US drug regulator's decision is expected to speed the vaccine's rollout in countries where the virus is most prevalent.